Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study of Clinical Markers for PARP Inhibitors in Epithelial Ovarian Cancer

NCT04582552 is registered in ClinicalTrials.gov with Xiaoxiang Chen as lead sponsor.

NCT NCT04582552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04582552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study of Clinical Markers for PARP Inhibitors in Epithelial Ovarian Cancer
Lead sponsor
Xiaoxiang Chen
Phase
Observational
Overall status
Unknown status
Start date
December 15, 2020
Completion date
November 30, 2023
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical marker, ovarian cancer, parp inhibitor